Favourites   Have ideas?  Sign in / Register

Positive:   Artificial Intelligence ↓8.75   Respiratory therapies / Pulmanory ↓4.22   RNA ↓4.19 «See more»   Blood ↑8.16   Disease: Oncology ↑10.11   Country: Canada ↑30.15

Negative:   Bad infrastructure  0.00


Immunology segment

ACRS Aclaris Therapeutics, Inc. - Common Stock -7.95% down -7.63% -0.32 + Immunology, Biopharma, Medicine


Last highlighted: #ACRS SEC report: Aclaris Therapeutics, Inc. Statement of changes in beneficial ownership of securities
SEC Filing Form 4 filed by Aclaris Therapeutics, Inc. -- SEC File Number
+ My List
ADTX ADiTx Therapeutics, Inc. - Common Stock -4.19% up -7.69% 3.5 + Immunology, RNA, Medicine

+ My List
AFMD Affimed N.V. - Common Stock 8.39% up 6.04% 2.35 + Immunology, Cancer fight, Medicine

+ My List
AGEN Agenus Inc. - Common Stock 8.75% down 9.87% -1.12 + Cancer fight, Immunology, Medicine


Last highlighted: #AGEN SEC report: AGENUS INC Statement of changes in beneficial ownership of securities
+ My List
AKER Akers Biosciences Inc. - Common Stock -11% -11% 0 + Medicine, Pharmaceutical , Immunology, Cancer fight

+ My List
ALDX Aldeyra Therapeutics, Inc. - Common Stock -7.14% up -8.24% 1.1 + Immunology, Medicine

+ My List
ALEC Alector, Inc. - Common Stock -14.7% down -14.19% -0.51 + Disease: Neurology/Alzheimer/Parkinson's, Immunology, Medicine


Last highlighted: #ALEC SEC report: Alector, Inc. Statement of changes in beneficial ownership of securities
SEC Filing Form 4 filed by Alector, Inc. -- SEC File Number
+ My List
ALT Altimmune, Inc. - Common Stock 5.31% down 7.15% -1.84 + Immunology, Biopharma, Medicine


Last highlighted: #ALT SEC report: Altimmune, Inc. Statement of changes in beneficial ownership of securities
SEC Filing Form 4 filed by Altimmune, Inc. -- SEC File Number
+ My List
ANAB AnaptysBio, Inc. - Common Stock -5.77% up -10.5% 4.73 + Immunology, Cancer fight, Medicine

+ My List
ANIX Anixa Biosciences, Inc. - Common Stock 7.09% up 2.23% 4.86 + Cancer fight, Medicine, Immunology

+ My List
APVO Aptevo Therapeutics Inc. - Common Stock 6.47% down 8.18% -1.71 + Biotechnology, Medicine, Disease: Oncology, Immunology


Last highlighted: $APVTW [15s. delayed] filed form 8-K on May 27, 09:02:28: Item7.01: Regulation FD https://t.co/MpE2r05xab
+ My List
ARGX argenx SE - American Depositary Shares 1.29% down 9.97% -8.68 + Immunology, Medicine

+ My List
ASLN ASLAN Pharmaceuticals Limited - American Depositary Shares 2.71% down 8.14% -5.43 + Country: Singapore, Pharmaceutical , Biopharma, Immunology, Medicine


Last highlighted: $ASLN / ASLAN Pharmaceuticals files form 6-K https://t.co/rm8jqdBSsq
+ My List
ATHX Athersys, Inc. - Common Stock 8.05% 8.05% 0 + Medicine, Immunology, Gene and cell, Disease: Cardiovascular, Disease: Neurology/Alzheimer/Parkinson's

+ My List
AUPH Aurinia Pharmaceuticals Inc - Common Shares -7.12% -7.12% 0 + Pharmaceutical , Immunology, Country: Canada


Last highlighted: FORM 10-Q [Quarterly Report] recently SEC filed. $AUPH #AuriniaPharmaceuticals Inc. Aurinia Pharmaceuticals Inc https://t.co/ei2FxR7sZR
+ My List
AVCO Avalon GloboCare Corp. - Common Stock up -9.9% 9.9 + Cancer fight, Medicine, Immunology, Pharmaceutical


Last highlighted: #AVCO SEC report: Avalon GloboCare Corp. Current report, items 1.01 and 9.01
SEC Filing Form 8-K filed by Avalon GloboCare Corp. -- SEC File Number 211089336
+ My List
BLCM Bellicum Pharmaceuticals, Inc. - Common Stock 1.3% up -8.48% 9.78 + Biopharma, Medicine, Immunology


Last highlighted: #BLCM SEC report: BELLICUM PHARMACEUTICALS, INC Statement of changes in beneficial ownership of securities
SEC Filing Form 4 filed by BELLICUM PHARMACEUTICALS, INC -- SEC File Number
+ My List
BNTX BioNTech SE - American Depositary Shares 3.06% down 11.04% -7.98 + Biotechnology, Immunology, Covid (fighting), Medicine


Last highlighted: #BNTX SEC report: BioNTech SE Report of foreign issuer [Rules 13a-16 and 15d-16]
SEC Filing Form 6-K filed by BioNTech SE -- SEC File Number 211142358
+ My List
BTAI BioXcel Therapeutics, Inc. - Common Stock -8.75% -8.75% 0 + Medicine, Immunology, Artificial Intelligence, Biopharma

+ My List
BYSI BeyondSpring, Inc. - Ordinary Shares -5.6% up -7.73% 2.13 + Cancer fight, Biopharma, Medicine, Immunology


Last highlighted: Form 6-K (report of foreign issuer [rules 13a-16 and 15d-16]) filed with the SEC $BYSI https://t.co/AH1YS5LVCR
+ My List
CABA Cabaletta Bio, Inc. - Common Stock 7.42% up 7.05% 0.37 + Gene and cell, Medicine, Immunology

+ My List
CCXI ChemoCentryx, Inc. - Common Stock -0.13% down 7.05% -7.18 + Biopharma, Cancer fight, Immunology, Medicine


Last highlighted: #CCXI SEC report: ChemoCentryx, Inc. Current report, items 7.01, 8.01, and 9.01
+ My List
CLDX Celldex Therapeutics, Inc. - Common Stock 6.55% down 7.16% -0.61 + Cancer fight, Immunology, Medicine


Last highlighted: #CLDX SEC report: Celldex Therapeutics, Inc. Current report, items 2.02 and 9.01
SEC Filing Form 8-K filed by Celldex Therapeutics, Inc. -- SEC File Number 211148052
+ My List
CRVS Corvus Pharmaceuticals, Inc. - Common Stock 50.44% up 36.4% 14.04 + Medicine, Immunology, Pharmaceutical

+ My List
CTSO Cytosorbents Corporation - Common Stock 2.14% down 8.84% -6.7 + Immunology, Medicine, Surgery


Last highlighted: #CTSO SEC report: Cytosorbents Corp Current report, items 8.01 and 9.01
SEC Filing Form 8-K filed by Cytosorbents Corp -- SEC File Number 211074173
+ My List
CUE Cue Biopharma, Inc. - Common Stock 1.62% down 7.56% -5.94 + Biopharma, Immunology, Cancer fight

+ My List
DBVT DBV Technologies S.A. - American Depositary Shares 6.88% down 8.01% -1.13 + Immunology, Biopharma, Medicine


Last highlighted: #DBVT SEC report: DBV Technologies S.A. Quarterly report [Sections 13 or 15(d)]
SEC Filing Form 10-Q filed by DBV Technologies S.A. -- SEC File Number 211136660
+ My List
DVAX Dynavax Technologies Corporation - Common Stock 5.54% down 7.75% -2.21 + Immunology, Biology, Biopharma, Medicine, Vaccines


Last highlighted: #DVAX SEC report: DYNAVAX TECHNOLOGIES CORP Statement of changes in beneficial ownership of securities
SEC Filing Form 4 filed by DYNAVAX TECHNOLOGIES CORP -- SEC File Number
+ My List
EDSA Edesa Biotech, Inc. - Common Shares 4.26% down 15.24% -10.98 + Medicine, Biopharma, Immunology

+ My List
ENOB Enochian Biosciences, Inc. - Common Stock 11.29% down 11.43% -0.14 + Disease: Infectious, Cancer fight, Immunology, Medicine

+ My List
FATE Fate Therapeutics, Inc. - Common Stock -0.44% down 7.88% -8.32 + Cancer fight, Immunology, Medicine

+ My List
GLSI Greenwich LifeSciences, Inc. - Common stock 4.66% down 8.81% -4.15 + Medicine, Biopharma, Cancer fight, Immunology

+ My List
GNCA Genocea Biosciences, Inc. - Common Stock 8.52% 8.52% 0 + Cancer fight, Immunology, Medicine

+ My List
GRTS Gritstone Oncology, Inc. - Common Stock -2.77% down 10.35% -13.12 + Medicine, Immunology, Cancer fight

+ My List
HGEN Humanigen, Inc. - Common Stock -57.04% up -57.79% 0.75 + Biopharma, Immunology, Cancer fight, Medicine


Last highlighted: #HGEN SEC report: HUMANIGEN, INC Current report, items 7.01 and 9.01
SEC Filing Form 8-K filed by HUMANIGEN, INC -- SEC File Number 211142187
+ My List
HOOK HOOKIPA Pharma Inc. - Common Stock -1.42% down 7.18% -8.6 + Disease: Infectious, Immunology, Cancer fight, Medicine

+ My List
HTGM HTG Molecular Diagnostics, Inc. - Common Stock 6.03% down 7.62% -1.59 + Immunology, Medicine


Last highlighted: #HTGM SEC report: HTG MOLECULAR DIAGNOSTICS, INC Statement of changes in beneficial ownership of securities
+ My List
IMNM Immunome, Inc. - Common Stock 12.2% 12.2% 0 + Cancer fight, Biotechnology, Medicine, Immunology

+ My List
IMTX Immatics N.V. - Ordinary Shares 3.03% down 7.62% -4.59 + Immunology, Cancer fight, Disease: Oncology, Medicine

+ My List
IMV IMV Inc. - Common Shares 5.16% down 8.39% -3.23 + Immunology, Medicine, Country: Canada, Covid (fighting), Biopharma


Last highlighted: #IMV SEC report: IMV Inc. Report of foreign issuer [Rules 13a-16 and 15d-16]
SEC Filing Form 6-K filed by IMV Inc. -- SEC File Number 211138178
+ My List
IMVT Immunovant, Inc. - Common Stock -0.83% down 7.19% -8.02 + Medicine, Immunology


Last highlighted: #IMVT SEC report: Immunovant, Inc. Statement of changes in beneficial ownership of securities
SEC Filing Form 4 filed by Immunovant, Inc. -- SEC File Number
+ My List
INMB INmune Bio Inc. - Common stock -8.74% up -9.26% 0.52 + Immunology, Cancer fight, Disease: Oncology, Medicine

+ My List
IOVA Iovance Biotherapeutics, Inc. - Common Stock -0.67% down 10.03% -10.7 + Biotechnology, Gene and cell, Immunology, Cancer fight, Disease: Oncology, T cell-based


Last highlighted: #IOVA SEC report: IOVANCE BIOTHERAPEUTICS, INC. Current report, items 2.02 and 9.01
SEC Filing Form 8-K filed by IOVANCE BIOTHERAPEUTICS, INC. -- SEC File Number 211148127
+ My List
ITOS iTeos Therapeutics, Inc. - Common Stock 2.54% 2.54% 0 + Cancer fight, Biopharma, Disease: Oncology, Immunology, Medicine


Last highlighted: $ITOS 📜 iTeos Therapeutics, Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement https://t.co/fsH6i8bthL 15s delayed.
+ My List
JNCE Jounce Therapeutics, Inc. - Common Stock 13.45% up 11.9% 1.55 + Immunology, Cancer fight, Medicine

+ My List
KRBP Kiromic BioPharma, Inc. - Common Stock 13.1% up 8.33% 4.77 + Biopharma, Cancer fight, Immunology, Medicine


Last highlighted: #KRBP SEC report: Kiromic Biopharma, Inc. Statement of acquisition of beneficial ownership by individuals
+ My List
KZR Kezar Life Sciences, Inc. - Common Stock -2.56% down 9.74% -12.3 + Immunology, Medicine

+ My List
MDNA Medicenna Therapeutics Corp. - Common Shares 0.38% down 10.59% -10.21 + Country: Canada, Immunology


Last highlighted: #MDNA SEC report: Medicenna Therapeutics Corp. Report of foreign issuer [Rules 13a-16 and 15d-16]
SEC Filing Form 6-K filed by Medicenna Therapeutics Corp. -- SEC File Number 211089394
+ My List
MGTA Magenta Therapeutics, Inc. - Common Stock 8.16% 8.16% 0 + Gene and cell, Cancer fight, Blood, Immunology, Medicine


Last highlighted: #MGTA SEC report: Magenta Therapeutics, Inc. Notice of Effectiveness
SEC Filing Form EFFECT filed by Magenta Therapeutics, Inc. -- SEC File Number 211084159
+ My List
MOR MorphoSys AG - American Depositary Shares 7.22% up 7.08% 0.14 + Biopharma, Medicine, Disease: Oncology, Immunology, Cancer fight

+ My List
MRKR Marker Therapeutics, Inc. - Common Stock 7.14% down 9.34% -2.2 + Immunology, Medicine, Cancer fight


Last highlighted: #MRKR SEC report: Marker Therapeutics, Inc. Current report, items 7.01 and 9.01
+ My List
NK NantKwest, Inc. - Common Stock 0.00% 0 + Cancer fight, Medicine, Immunology
- Bad infrastructure
+ My List
NLTX Neoleukin Therapeutics, Inc. - Common Stock 3.76% down 7.13% -3.37 + Medicine, Immunology


Last highlighted: #NLTX SEC report: Neoleukin Therapeutics, Inc. Current report, items 2.02, 7.01, and 9.01
SEC Filing Form 8-K filed by Neoleukin Therapeutics, Inc. -- SEC File Number 211148247
+ My List
NRIX Nurix Therapeutics, Inc. - Common stock 6.06% down 8.27% -2.21 + Biotechnology, Cancer fight, Immunology


Last highlighted: #NRIX SEC report: Nurix Therapeutics, Inc. Current report, items 2.02 and 9.01
SEC Filing Form 8-K filed by Nurix Therapeutics, Inc. -- SEC File Number 211088020
+ My List
ONCR Oncorus, Inc. - Common Stock -8.47% down -7.81% -0.66 + Cancer fight, Immunology, Biotechnology


Last highlighted: #ONCR SEC report: Oncorus, Inc. Current report, items 2.02 and 9.01
SEC Filing Form 8-K filed by Oncorus, Inc. -- SEC File Number 211142316
+ My List
ONCS OncoSec Medical Incorporated - Common Stock -8.26% -8.26% 0 + Cancer fight, Disease: Oncology, Medicine, Immunology


Last highlighted: #ONCS SEC report: ONCOSEC MEDICAL Inc Statement of changes in beneficial ownership of securities
SEC Filing Form 4 filed by ONCOSEC MEDICAL Inc -- SEC File Number
+ My List
ONCY Oncolytics Biotech Inc. - Common Shares -2.15% down 12.56% -14.71 + Medicine, Cancer fight, Country: Canada, Immunology


Last highlighted: $ONCY / Oncolytics Biotech files form 6-K https://t.co/G1byP6giz8
+ My List
PAND Pandion Therapeutics Inc. - Common stock 0.17% 0.17% 0 + Immunology, Medicine, Organ transplants


Last highlighted: SEC Form 8-K [Press/News Current Report] filed by $PAND #PandionTherapeutics, Inc https://t.co/uNtZ9rhD94
+ My List
PDSB PDS Biotechnology Corporation - Common Stock 4.86% down 7.35% -2.49 + Biotechnology, Immunology, Cancer fight, Disease: Oncology, Medicine


Last highlighted: RT @EdgarInsider: FORM 8-K [Press/News Current Report] recently SEC filed. $PDSB $EDGE PDS Biotechnology Corp https://t.co/FKxSQ3btJT
+ My List
PHIO Phio Pharmaceuticals Corp. - Common Stock 8.49% up 2.83% 5.66 + Medicine, Cancer fight, Immunology


Last highlighted: #PHIO SEC report: Phio Pharmaceuticals Corp. Statement of changes in beneficial ownership of securities
SEC Filing Form 4 filed by Phio Pharmaceuticals Corp. -- SEC File Number
+ My List
PIRS Pieris Pharmaceuticals, Inc. - Common Stock -4.22% down 11.62% -15.84 + Biopharma, Respiratory therapies / Pulmanory, Medicine, Immunology, Cancer fight


Last highlighted: #PIRS SEC report: PIERIS PHARMACEUTICALS, INC. Current report, items 2.02, 7.01, and 9.01
SEC Filing Form 8-K filed by PIERIS PHARMACEUTICALS, INC. -- SEC File Number 211142334
+ My List
PRVB Provention Bio, Inc. - Common Stock 1.61% up -7.44% 9.05 + Immunology, Medicine


Last highlighted: #PRVB SEC report: Provention Bio, Inc. Statement of changes in beneficial ownership of securities
SEC Filing Form 4 filed by Provention Bio, Inc. -- SEC File Number
+ My List
QDEL Quidel Corporation - Common Stock -1.71% -1.71% 0 + Medicine, Disease: Infectious, Immunology


Last highlighted: $QDEL 8-K Quidel (22 Apr, 4:53pm) 📰 Quidel Announces Preliminary Revenue for First Quarter 2021 https://t.co/LsfiDmSNca #QDEL #8K #Quidel #News
+ My List
SELB Selecta Biosciences, Inc. - Common Stock 6.48% down 7.73% -1.25 + Biotechnology, Immunology, Biology, Medicine


Last highlighted: $SELB Selecta Biosciences, Inc. SEC Filing: Form 8-K https://t.co/0XklTmmzMS
+ My List
SURF Surface Oncology, Inc. - Common Stock 13.37% 13.37% 0 + Cancer fight, Immunology, Medicine


Last highlighted: #SURF SEC report: Surface Oncology, Inc. Current report, items 5.02 and 9.01
SEC Filing Form 8-K filed by Surface Oncology, Inc. -- SEC File Number 211078938
+ My List
TNXP Tonix Pharmaceuticals Holding Corp. - Common Stock up -35.29% 35.29 + Medicine, Biopharma, Immunology, Disease: Addictions, Disease: Neurology/Alzheimer/Parkinson's, Disease: Central nervous system (CNS)


Last highlighted: $TNXP TONIX PHARMACEUTICALS HOLDING CORP. (NASDAQ:TNXP) Files An 8-K Regulation FD Disclosure https://t.co/hFCRf3OmpX
+ My List
TRIL Trillium Therapeutics Inc. - Common Shares 189.49% down 189.66% -0.16999999999999 + Country: Canada, Cancer fight, Disease: Oncology, Immunology


Last highlighted: #TRIL SEC report: Trillium Therapeutics Inc. Statement of changes in beneficial ownership of securities
SEC Filing Form 4 filed by Trillium Therapeutics Inc. -- SEC File Number
+ My List
VIR Vir Biotechnology, Inc. - Common Stock -6.84% up -7.18% 0.34 + Immunology, Medicine


Last highlighted: #VIR SEC report: Vir Biotechnology, Inc. Current report, items 2.02 and 9.01
SEC Filing Form 8-K filed by Vir Biotechnology, Inc. -- SEC File Number 211148349
+ My List
ZIOP ZIOPHARM Oncology Inc - Common Stock -1.79% up -10.44% 8.65 + T cell-based, Cancer fight, Disease: Oncology, Immunology, Medicine

+ My List
BCTX BriaCell Therapeutics Corp. - Common Shares 5.31% down 7.41% -2.1 + Cancer fight, Immunology, Medicine, Disease: Oncology


Last highlighted: #BCTX SEC report: BriaCell Therapeutics Corp. Report of foreign issuer [Rules 13a-16 and 15d-16]
SEC Filing Form 6-K filed by BriaCell Therapeutics Corp. -- SEC File Number 211182540
+ My List
BOLT Bolt Biotherapeutics, Inc. - Common Stock -9.19% -9.19% 0 + Immunology, Cancer fight, Disease: Oncology, Medicine

+ My List
EVAX Evaxion Biotech A/S - American Depositary Share -7.95% -7.95% 0 + Cancer fight, Disease: Oncology, Immunology, Medicine, Biotechnology, Biology


Last highlighted: #EVAX SEC report: Evaxion Biotech A/S Report of foreign issuer [Rules 13a-16 and 15d-16]
SEC Filing Form 6-K filed by Evaxion Biotech A/S -- SEC File Number 211078935
+ My List
FSTX F-star Therapeutics, Inc. - Common Stock 1.05% down 12.63% -11.58 + Immunology, Medicine, Cancer fight, Disease: Oncology


Last highlighted: #FSTX SEC report: F-star Therapeutics, Inc. Statement of changes in beneficial ownership of securities
SEC Filing Form 4 filed by F-star Therapeutics, Inc. -- SEC File Number
+ My List
GTBP GT Biopharma, Inc. - Common Stock -9.77% down -7.91% -1.86 + Biopharma, Medicine, Disease: Oncology, Immunology, Cancer fight


Last highlighted: #GTBP SEC report: GT Biopharma, Inc. Notification of inability to timely file Form 10-Q or 10-QSB
SEC Filing Form NT 10-Q filed by GT Biopharma, Inc. -- SEC File Number 211181131
+ My List
NEXI NexImmune, Inc. - Common Stock 8.96% 8.96% 0 + Medicine, Immunology


Last highlighted: A Form 10-Q [Quarterly Report] filing has been made with the SEC: $NEXI #NexImmune, Inc. #NexImmune, Inc https://t.co/SsyxY2SUAE
+ My List
PRTG Portage Biotech Inc. - Common Stock -4.87% up -7.37% 2.5 + Country: Canada, Immunology, Cancer fight, Disease: Oncology

+ My List
RXDX Prometheus Biosciences, Inc. - Common Stock 7.7% down 8.02% -0.32 + Biotechnology, Medicine, Diagnosing, Immunology

+ My List
SCPS Scopus BioPharma Inc. - Common Stock 3.12% down 8.41% -5.29 + Immunology, Cancer fight, Medicine, Disease: Oncology, Biopharma


Last highlighted: Alert [Quarterly Report] / Form 10-Q filed with the SEC $SCPS Scopus BioPharma Inc. Scopus BioPharma Inc https://t.co/lmBK4v1IJB
+ My List


We do not provide financial advice. All displayed data is the result of experiments, and a subjective assessment. All decisions that will be made based on this data are made at your own risk. Thank you for understanding.